Kymera Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.05x
Net debt / equity: -0.04x
Debt / assets: 0.05x
Debt / EBITDA: -0.26x
Net debt / EBITDA: 0.21x

Liquidity & coverage

Current ratio: 10.81x
Quick ratio: 10.81x
Cash ratio: 10.39x
Interest coverage: —
EBITDA / interest: —
Working capital: $614.8M

Cash & dividend

FCF / debt: -3.03x
Cash flow / debt: -3.01x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.